Laura Joszt, MA

Although histotripsy, a novel technique utilizing high-frequency ultrasound waves to destroy tumors, is only being used in the liver, it is being looked at in other solid tumors, like kidney, prostate, and pancreas, explained Shaun P. McKenzie, MD, FACS, a […]

A real-world analysis of avelumab and axitinib to treat advanced renal cell carcinoma supports the frontline use of the combination and confirmed the findings of JAVELIN Renal 101 (NCT02684006), said Axel Merseburger, MD, professor of urology and chairman of the

Despite clinical trial findings, real-world evidence shows adding 6 months of neoadjuvant deprivation therapy (NADT) to external-beam radiation therapy (EBRT) for patients with intermediate-risk prostate cancer did not improve prostate cancer–specific survival or overall survival, explained Barry Goy, MD, a

While cisplatin chemotherapy is the first-line treatment for perioperative management of invasive urothelial cancer, patients with upper tract urothelial cancer are ineligible for cisplatin for a variety of reasons, such as comorbidities or surgery-related renal function. However, enfortumab vedotin with

After initial diagnosis of a myeloproliferative neoplasm, such as essential thrombocytopenia (ET) or polycythemia vera (PV), patients will undergo an intensive period of monitoring to understand the behavior of their individual disease, said Jennifer Vaughn, MD, hematologist-oncologist and assistant professor

The significant symptom burden of myelofibrosis requires treatment to control symptoms, but the Janus kinase (JAK) inhibitors being used today can cause significant side effects that are hard to manage through dose adjustment or reduction and may require patients to

Patients with polycythemia vera (PV) fall on a spectrum of risk for thrombotic events, which can be one of the factors that comes into play when choosing therapy, explained Jennifer Vaughn, MD, hematologist-oncologist and assistant professor in the Division of

Advances in therapy are improving outcomes for patients, but the incidence and mortality rates for hepatocellular carcinoma is increasing in the US. Image credit: Jo Panuwat D – stock.adobe.com Recent research in hepatocellular carcinoma (HCC) highlighted the importance of screening

Multiple drugs received complete response letters, while some biologics gained their first biosimilars, which also received interchangeability, and a treatment with the first new mechanism in decades was approved in schizophrenia. Image Credit: Pawel – stock.adobe.com Among the many FDA

Managing a younger person with a myeloproliferative neoplasm (MPN) includes a lot of long-term considerations, including their chance of progressing to a more aggressive disease, like acute myeloid leukemia, said Jennifer Vaughn, MD, hematologist-oncologist and assistant professor in the Division